Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing Prestwick3_000544 listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

Prestwick3_000544
Canada

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Prestwick3_000544

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 14 USDMF, 7 CEP/COS, 1 JDMF, 12 KDMF, 8 NDC API, 13 Listed Suppliers, $ API Reference Price

26 API Suppliers
14 USDMF
7 CEP/COS
1 JDMF
12 KDMF
8 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

166 FDF Dossiers, 36 FDA Orange Book, 65 Europe, 7 Canada, 16 Australia, 13 South Africa, 29 Listed Dossiers

166 FDF Dossiers
36 FDA Orange Book
65 Europe
7 Canada
16 Australia
13 South Africa
29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 28MG, SOLUTION/DROPS;OPHTHALMIC - 0.3%, OINTMENT;OPHTHALMIC - 0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SOLUTION;INHALATION - 300MG/5ML, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

POWDER;INHALATION - 28MG
SOLUTION/DROPS;OPHTHALMIC - 0.3%
OINTMENT;OPHTHALMIC - 0.3%
SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%
OINTMENT;OPHTHALMIC - 0.1%;0.3%
SOLUTION;INHALATION - 300MG/5ML
SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 7 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 6 Actylis, 1 BASF, 1 Curia, 3 Finar, 1 Microlex e.U, 1 Nippon Fine Chemical, 1 Valens Pharmachem

1 Rochem International Inc
7 DKSH
1 Pharm-RX Chemical
1 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
6 Actylis
1 BASF
1 Curia
3 Finar
1 Microlex e.U
1 Nippon Fine Chemical
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

10 Topical, 9 Thickeners and Stabilizers, 8 Parenteral, 6 Solubilizers, 5 Rheology Modifiers, 2 Emulsifying Agents, 2 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents, 1 API Stability Enhancers, 1 Dry Powder Inhalation, 1 Fillers, Diluents & Binders

10 Topical
9 Thickeners and Stabilizers
8 Parenteral
6 Solubilizers
5 Rheology Modifiers
2 Emulsifying Agents
2 Film Formers & Plasticizers
1 Surfactant & Foaming Agents
1 API Stability Enhancers
1 Dry Powder Inhalation
1 Fillers, Diluents & Binders

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 34 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
34 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 50 Finished Drug Prices, 2 Annual Reports

5 US Medicaid Prescriptions
50 Finished Drug Prices
2 Annual Reports

MARKET PLACE

29 APIs, 6 FDF Dossiers

29 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 3 Health Canada Patents

10 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 2 Others

4 EDQM
1 USP
2 Others

$ API Ref.Price (USD/KG) : 2,226 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 1BGP PHARMA ULC

02 4NOVARTIS PHARMACEUTICALS CANADA INC

03 1Pharmascience Inc.

04 1SANDOZ CANADA INCORPORATED

filter Active Ingredients Reset all filters

7 All

01 6TOBRAMYCIN

02 1Tobramycin

filter Dosage Form Reset all filters

7 All

01 1CAPSULE

02 1LIQUID

03 2OINTMENT

04 2SOLUTION

05 1SUSPENSION

filter Brand Name Reset all filters

7 All

01 1PMS-TOBRAMYCIN 0.3% OPHTHALMIC SOLUTION

02 1SANDOZ TOBRAMYCIN

03 1TOBI PODHALER

04 2TOBRADEX

05 2TOBREX

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

BGP PHARMA ULC

AAPS 2024

Not Confirmed

BGP PHARMA ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TOBI PODHALER

Dosage Form : CAPSULE

Dosage Strength : 28MG

Packaging : 56

Approval Date :

Application Number : 2365154

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TOBRADEX

Dosage Form : SUSPENSION

Dosage Strength : 0.3%/W/V

Packaging : 3/5ML

Approval Date :

Application Number : 778907

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TOBRADEX

Dosage Form : OINTMENT

Dosage Strength : 0.3%/W/W

Packaging : 3.5G

Approval Date :

Application Number : 778915

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TOBREX

Dosage Form : OINTMENT

Dosage Strength : 0.3%/W/W

Packaging : 3.5G

Approval Date :

Application Number : 614254

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TOBREX

Dosage Form : SOLUTION

Dosage Strength : 0.3%/W/V

Packaging : 5ML

Approval Date :

Application Number : 513962

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-TOBRAMYCIN 0.3% OPHTHALMIC SOLUTION

Dosage Form : LIQUID

Dosage Strength : 3MG

Packaging : 5ML

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

SANDOZ CANADA INCORPORATED

AAPS 2024

Not Confirmed

SANDOZ CANADA INCORPORATED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : SANDOZ TOBRAMYCIN

Dosage Form : SOLUTION

Dosage Strength : 0.3%

Packaging : 5ML

Approval Date :

Application Number : 2241755

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?